ADVANCED Medical Solutions (AMS) operates in two business segments: advance wound care and wound closure and sealants. It also has a joint venture in the Netherlands, manufacturing hydrophilic polyurethane foam.
Advanced Medical Solutions
32.5p -0.5p
Scotsman says BUYThe wound-care business develops, makes and distributes polymer wound dressings, while the wound closure and sealants business unit develops, makes and distrib
utes medical adhesives and products for closing and sealing tissues.
AMS came into being in 1991 and is now listed on Aim. The company is in the vanguard of innovative healthcare treatments. The wound-sealant healing is particularly interesting, using an innovative super glue that has already been successfully deployed in Europe. The company is confident it will be allowed to market and distribute to the important US market.
AMS is working with the NHS, while developing its operations abroad. For 2007, pre-tax profits increased threefold to £1.9 million with earnings per share rising to 1.55p; net cash increased to £7.2m, giving the company a platform from which to make acquisitions and perhaps pay a maiden dividend.
AMS's markets are competitive and dominated by some substantial companies such as Johnson & Johnson and Kimberley-Clark, but the group has already established an impressive record and has potentially exciting new products, while its existing propositions are well protected by patent. With the company already well established at home, and looking at considerable potential overseas, the shares are one of the more interesting prospects in the healthcare industry.
• The value of your investment could fall and you may get back less than you invested. You should take professional advice if you have any doubt about the suitability of this company for your portfolio.
The full article contains 293 words and appears in The Scotsman newspaper.
